| Pooling of samples for testing for SARS-CoV-2 in asymptomatic people S Lohse, T Pfuhl, B Berkó-Göttel, J Rissland, T Geißler, B Gärtner, ... The Lancet Infectious Diseases 20 (11), 1231-1232, 2020 | 372 | 2020 |
| Human IgG2 antibodies against epidermal growth factor receptor effectively trigger antibody-dependent cellular cytotoxicity but, in contrast to IgG1, only by cells of myeloid … T Schneider-Merck, JJ Lammerts van Bueren, S Berger, K Rossen, ... The journal of immunology 184 (1), 512-520, 2010 | 269 | 2010 |
| IgA EGFR antibodies mediate tumour killing in vivo P Boross, S Lohse, M Nederend, JHM Jansen, G van Tetering, M Dechant, ... EMBO molecular medicine 5 (8), 1213-1226, 2013 | 132 | 2013 |
| Targeting FcαRI on polymorphonuclear cells induces tumor cell killing through autophagy JE Bakema, SH Ganzevles, DM Fluitsma, MW Schilham, RHJ Beelen, ... The Journal of Immunology 187 (2), 726-732, 2011 | 94 | 2011 |
| Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killing S Lohse, S Derer, T Beyer, K Klausz, M Peipp, JHW Leusen, ... The Journal of Immunology 186 (6), 3770-3778, 2011 | 89 | 2011 |
| Impact of epidermal growth factor receptor (EGFR) cell surface expression levels on effector mechanisms of EGFR antibodies S Derer, P Bauer, S Lohse, AH Scheel, S Berger, C Kellner, M Peipp, ... The Journal of Immunology 189 (11), 5230-5239, 2012 | 88 | 2012 |
| Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity M Becker, M Strengert, D Junker, PD Kaiser, T Kerrinnes, B Traenkle, ... Nature communications 12 (1), 1152, 2021 | 75 | 2021 |
| Characterization of BK polyomaviruses from kidney transplant recipients suggests a role for APOBEC3 in driving in-host virus evolution A Peretti, EM Geoghegan, DV Pastrana, S Smola, P Feld, M Sauter, ... Cell host & microbe 23 (5), 628-635. e7, 2018 | 75 | 2018 |
| An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo S Lohse, S Meyer, LAPM Meulenbroek, JHM Jansen, M Nederend, ... Cancer research 76 (2), 403-417, 2016 | 72 | 2016 |
| Serum-free production and purification of chimeric IgA antibodies T Beyer, S Lohse, S Berger, M Peipp, T Valerius, M Dechant Journal of immunological methods 346 (1-2), 26-37, 2009 | 68 | 2009 |
| IL-1RA antibodies in myocarditis after SARS-CoV-2 vaccination L Thurner, C Kessel, N Fadle, E Regitz, F Seidel, I Kindermann, S Lohse, ... New England Journal of Medicine 387 (16), 1524-1527, 2022 | 65 | 2022 |
| Fc‐engineered EGF‐R antibodies mediate improved antibody‐dependent cellular cytotoxicity (ADCC) against KRAS‐mutated tumor cells M Schlaeth, S Berger, S Derer, K Klausz, S Lohse, M Dechant, GA Lazar, ... Cancer science 101 (5), 1080-1088, 2010 | 60 | 2010 |
| Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicity S Derer, P Glorius, M Schlaeth, S Lohse, K Klausz, U Muchhal, ... MAbs 6 (2), 409-421, 2014 | 59 | 2014 |
| Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study J Pfeifer, B Thurner, C Kessel, N Fadle, P Kheiroddin, E Regitz, ... The Lancet Rheumatology 4 (5), e329-e337, 2022 | 55 | 2022 |
| Simultaneous targeting of FcγRs and FcαRI enhances tumor cell killing AM Brandsma, T Ten Broeke, M Nederend, LAPM Meulenbroek, ... Cancer immunology research 3 (12), 1316-1324, 2015 | 51 | 2015 |
| Characterization of a mutated IgA2 antibody of the m (1) allotype against the epidermal growth factor receptor for the recruitment of monocytes and macrophages S Lohse, C Brunke, S Derer, M Peipp, P Boross, C Kellner, T Beyer, ... Journal of Biological Chemistry 287 (30), 25139-25150, 2012 | 50 | 2012 |
| HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity M Peipp, S Derer, S Lohse, M Staudinger, K Klausz, T Valerius, ... Oncotarget 6 (31), 32075, 2015 | 47 | 2015 |
| Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity (ADCC), and complement dependent … S Lohse, S Loew, A Kretschmer, JH Jansen, S Meyer, T Ten Broeke, ... British Journal of Haematology 181 (3), 413-417, 2018 | 42 | 2018 |
| Pooled RT-qPCR testing for SARS-CoV-2 surveillance in schools-a cluster randomised trial A Joachim, F Dewald, I Suarez, M Zemlin, I Lang, R Stutz, A Marthaler, ... EClinicalMedicine 39, 2021 | 38 | 2021 |
| Complement‐mediated tumor‐specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII) K Klausz, S Berger, JJ Lammerts van Bueren, S Derer, S Lohse, ... Cancer science 102 (10), 1761-1768, 2011 | 35 | 2011 |
